Table 2 Socio-demographic and clinical characteristics of patients
|  | N. (%) | Mean ± SD | Median (minimum–maximum) |
|---|---|---|---|
Age (years) |  | 36.1 ± 6.87 | 34.5 (25.0–52.0) |
Sex: male | 21 (52.5) | Â | Â |
Female | 19 (47.5) | Â | Â |
Current smoker | 12 (30.0) | Â | Â |
Coital frequency/week: 1 | 16 (40.0) | Â | Â |
 2 | 15 (37.5) |  |  |
 3 | 9 (22.5) |  |  |
MS type: SPMS | 7 (17.5) | Â | Â |
RRMS | 33 (82.5) | Â | Â |
Medication | Â | Â | Â |
 Fingolimod | 8 (20.0%) |  |  |
 Interferon | 17 (42.5%) |  |  |
 Imuran | 3 (7.5%) |  |  |
 Dimethyl fumarate | 7 (17.5%) |  |  |
 Teriflunomide | 3 (7.5%) |  |  |
 Ocrelizumab | 2 (5.0%) |  |  |
BMI ≥ 25 | 17 (42.5%) | 29.43 ± 6.88 | 28.9 (23.2–37.5) |
Marriage duration (years) |  | 9.9 ± 6.13 | 8.5 (3.0–28.0) |
Disease duration (years) |  | 8.68 ± 6.87 | 6 (2.0–28.0) |